Ligand price target raised to $157 from $144 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Ligand (LGND) to $157 from $144 and keeps a Buy rating on the shares ahead of the Q3 report. The firm updated Ligand’s valuation based on recent deals. It is “looking for continued ramp of smart deals.”